Liquidia (LQDA) Non-Current Assets (2019 - 2026)
Liquidia (LQDA) posted quarterly Non-Current Assets of $68.5 million for Q1 2026, up 36.35% year-over-year from $50.2 million in Q1 2025, and up 25.57% quarter-over-quarter from $54.5 million in Q4 2025.
Liquidia (LQDA) Non-Current Assets (2019 - 2026) Analysis & Trends
Liquidia's Non-Current Assets history runs 8 years deep, the most recent figure standing at $68.5 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 36.35% year-over-year to $68.5 million; the TTM figure through Mar 2026 stood at $234.1 million (up 42.56% YoY), while the FY2025 annual figure was $54.5 million, up 20.63% from the prior year.
- Non-Current Assets for Q1 2026 stood at $68.5 million, up from $54.5 million in the prior quarter.
- The five-year high for Non-Current Assets was $68.5 million in Q1 2026, with the low at $28.4 million in Q4 2023.
- The 5-year median for Non-Current Assets is $30.6 million (2022), against an average of $39.0 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets fell 10.08% in 2022, then surged 105.41% in 2025.
- Liquidia's Non-Current Assets stood at $29.4 million in 2022, then slipped by 3.25% to $28.4 million in 2023, then surged by 59.0% to $45.2 million in 2024, then increased by 20.63% to $54.5 million in 2025, then gained by 25.57% to $68.5 million in 2026.
- Business Quant data shows LQDA's Non-Current Assets at $68.5 million in Q1 2026, $54.5 million in Q4 2025, and $49.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 2.96 Bn |
| 10 | Liquidia | 6.35 Bn | 6.07 Bn | 160.92 Mn | 84.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.21 Mn |
| Mar 31, 2026 | 68.48 Mn |
| Dec 31, 2025 | 54.53 Mn |
| Sep 30, 2025 | 49.26 Mn |
| Jun 30, 2025 | 61.83 Mn |
| Mar 31, 2025 | 50.22 Mn |
| Dec 31, 2024 | 45.21 Mn |
| Sep 30, 2024 | 38.67 Mn |
| Jun 30, 2024 | 30.10 Mn |
| Mar 31, 2024 | 29.18 Mn |
| Dec 31, 2023 | 28.43 Mn |
| Sep 30, 2023 | 28.66 Mn |
| Jun 30, 2023 | 28.71 Mn |
| Mar 31, 2023 | 29.23 Mn |
| Dec 31, 2022 | 29.39 Mn |
| Sep 30, 2022 | 29.51 Mn |
| Jun 30, 2022 | 30.58 Mn |
| Mar 31, 2022 | 31.57 Mn |
| Dec 31, 2021 | 32.45 Mn |
| Sep 30, 2021 | 32.82 Mn |